Continued improvement in fundamentals and technicals could carry Palantir to megacap scale. A $1 trillion market cap is a realistic destination for strong growth companies, and Palantir appears on that path, though its timing is uncertain. Drawdowns remain opportunities to accumulate until the thesis changes. x.com 

Palantir's government contract activity is growing sharply, supporting its resilience despite the share-price pullback. Its $2.1 billion in 12-month obligations is up 184% from the prior year, among the strongest increases tracked. The Cryptic Bottom Index remains green despite the pullback. Its score is among the highest in the Cryptic Research System, led by growth and profitability, though catalysts and valuation score weakest. x.com  x.com  x.com 

Palantir's valuation is extreme relative to established defense companies. At $137 a share and a fully diluted market cap above $350 billion, the same money could buy Northrop Grumman, General Dynamics and Lockheed Martin with enough left for L3Harris. x.com 

Rising regional conflicts and soaring NATO spending commitments favor defense companies such as Rocket Lab and RTX, which carry massive multi-year backlogs. Rocket Lab, a $40 billion space launch and defense technology player, is up about 2,700% from its lows. RTX is up a more modest 69% but acts as a remarkably safe, high-yielding haven when institutions rotate. Both sit on the winning side of a 2026 market where money is rotating into favored sectors rather than lifting the whole index. x.com 

AeroVironment, Kratos, Axon, Lockheed Martin and Palantir win as the FY2027 defense budget is projected at $1.5 trillion, about $400 billion above this year. AeroVironment's revenue rose 143% with a record $1.1B funded backlog as the Pentagon orders Switchblade drones by the thousands. Kratos has a record $2B backlog for low-cost autonomous jets. Axon's revenue rose 34% with $14.3B in future bookings. Lockheed's backlog hit $186.4B. Palantir is the AI software layer under autonomous warfare. … Show more

Palantir's share price demands unusually fast cash and profit growth despite its strong business. At roughly $210, it implies 48.5% annual growth for five years; at 32% annual growth, the shares would be worth $96.64. It is a Watch, not a Buy at today's prices. Q2 sales rose 93% and cash flow after employee stock pay was $2.52 billion over 12 months, but government concentration, cancellable contracts and rising stock pay remain risks. x.com  x.com  x.com  x.com  x.com  x.com  x.com  x.com 

Palantir is irreplaceable even if it is probably overvalued on traditional metrics at $150. Its government contract moats, new defense AI deals and one of the most defensible software positions in enterprise AI support the stock. Overvalued and irreplaceable are not mutually exclusive. x.com 

Defense money is rotating into next-generation drone makers such as AeroVironment and Red Cat, not just legacy plays like Lockheed's F-35, after NATO members pledged 5% of GDP to defense, roughly a second U.S. military budget. x.com 

Palantir's roughly $500B market cap and 80x sales make it prudent to trim exposure despite continued affection for the company. Its tenfold run has already delivered substantial gains, not just the beginning; smaller speculative positions are getting crushed in this environment. x.com  x.com 

RTX benefits from Pratt & Whitney's recovering jet-engine business alongside rising global defense budgets. In Q3 FY26, sales rose 11%, operating profit 32% with margins expanding, and net income to common 35%; basic EPS rose from $1.43 to $1.91. Grade A: RTX sits in the sweet spot as the world rearms and flies more. x.com